218 related articles for article (PubMed ID: 32566689)
1. Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against
Norouzi F; Behrouz B; Ranjbar M; Mousavi Gargari SL
J Immunol Res; 2020; 2020():7840631. PubMed ID: 32566689
[TBL] [Abstract][Full Text] [Related]
2. Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models.
Ranjbar M; Behrouz B; Norouzi F; Mousavi Gargari SL
Mol Immunol; 2019 Dec; 116():98-105. PubMed ID: 31634816
[TBL] [Abstract][Full Text] [Related]
3. Anti-flagellin IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound murine models in a non-type-specific mode.
Ahmadi TS; Mousavi Gargari SL; Talei D
Mol Immunol; 2021 Aug; 136():118-127. PubMed ID: 34130152
[TBL] [Abstract][Full Text] [Related]
4. Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.
Peluso L; de Luca C; Bozza S; Leonardi A; Giovannini G; Lavorgna A; De Rosa G; Mascolo M; Ortega De Luna L; Catania MR; Romani L; Rossano F
BMC Microbiol; 2010 Jan; 10():9. PubMed ID: 20070893
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
[TBL] [Abstract][Full Text] [Related]
6. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of properties of Pseudomonas aeruginosa recombinant outer membrane protein F (OprF)].
Zlygostev SA; Gataullin AG; Kaloshin AA; Mikhaĭlova NA; Zverev VV
Zh Mikrobiol Epidemiol Immunobiol; 2006; (7):43-7. PubMed ID: 17297879
[TBL] [Abstract][Full Text] [Related]
8. Passive immunization with anti- chimeric protein PilQ/PilA -DSL region IgY does not protect against mortality associated with Pseudomonas aeruginosa sepsis in a rabbit model.
Zamani K; Irajian G; Zahedi Bialvaei A; Zahraei Salehi T; Khormali M; Vosough A; Masjedian Jazi F
Mol Immunol; 2022 Jan; 141():258-264. PubMed ID: 34896925
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of Pseudomonas aeruginosa recombinant outer-membrane protein F and the study of its antigenic properties].
Kaloshin AA; Zlygostev SA; Toropchina IuN; Kurbatova EA; Zverev VV; Mikhaĭlova NA
Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):50-3. PubMed ID: 16279535
[TBL] [Abstract][Full Text] [Related]
10. Recombinant outer membrane protein F-B subunit of LT protein as a prophylactic measure against Pseudomonas aeruginosa burn infection in mice.
Farsani HH; Rasooli I; Gargari SL; Nazarian S; Astaneh SD
World J Methodol; 2015 Dec; 5(4):230-7. PubMed ID: 26713284
[TBL] [Abstract][Full Text] [Related]
11. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.
Krause A; Whu WZ; Xu Y; Joh J; Crystal RG; Worgall S
Vaccine; 2011 Mar; 29(11):2131-9. PubMed ID: 21215829
[TBL] [Abstract][Full Text] [Related]
12. Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.
Mansouri E; Blome-Eberwein S; Gabelsberger J; Germann G; von Specht BU
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):161-6. PubMed ID: 12832120
[TBL] [Abstract][Full Text] [Related]
13. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
[TBL] [Abstract][Full Text] [Related]
14. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
[TBL] [Abstract][Full Text] [Related]
15. Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.
Price BM; Galloway DR; Baker NR; Gilleland LB; Staczek J; Gilleland HE
Infect Immun; 2001 May; 69(5):3510-5. PubMed ID: 11292786
[TBL] [Abstract][Full Text] [Related]
16. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
[TBL] [Abstract][Full Text] [Related]
17. Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model.
Thomsen K; Christophersen L; Bjarnsholt T; Jensen PØ; Moser C; Høiby N
J Cyst Fibros; 2016 Mar; 15(2):171-8. PubMed ID: 26303991
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
[TBL] [Abstract][Full Text] [Related]
19. Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.
von Specht BU; Knapp B; Muth G; Bröker M; Hungerer KD; Diehl KD; Massarrat K; Seemann A; Domdey H
Infect Immun; 1995 May; 63(5):1855-62. PubMed ID: 7729895
[TBL] [Abstract][Full Text] [Related]
20. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
